Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma

被引:0
|
作者
Tao, Haisu [1 ,2 ]
Zhang, Yuxin [1 ,2 ]
Yuan, Tong [1 ,2 ]
Li, Jiang [1 ,2 ]
Liu, Junjie [1 ,2 ]
Xiong, Yixiao [1 ,2 ]
Zhu, Jinghan [1 ,2 ]
Huang, Zhiyong [1 ,2 ]
Wang, Ping [3 ]
Liang, Huifang [1 ,2 ]
Zhang, Erlei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China
[2] Hubei Key Lab Hepatopancreato Biliary Dis, Wuhan, Peoples R China
[3] Guangzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
AGING-US | 2022年 / 14卷 / 03期
基金
中国国家自然科学基金;
关键词
HCC; EMT; prognostic signature; LINC01116; immune; MESENCHYMAL TRANSITION; METASTASIS; EZH2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Epithelial-mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. YResults: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management.
引用
收藏
页码:1473 / 1491
页数:19
相关论文
共 50 条
  • [1] Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
    Xu, Qianhui
    Wang, Yuxin
    Huang, Wen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [2] Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
    Feng, Chunyu
    Liu, Shaopeng
    Shang, Zhengjun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [3] Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma
    Yuan, Mengqin
    Wang, Yanqing
    Sun, Qinqian
    Liu, Shiyi
    Xian, Shu
    Dai, Fangfang
    Zhang, Li
    Fan, Yaqi
    Wang, Feiyan
    Yang, Dongyong
    Zheng, Yajing
    Deng, Zhimin
    Tan, Wei
    Liu, Yeqiang
    Cheng, Yanxiang
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [4] Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
    Li, Danfeng
    Lin, Xiaosheng
    Chen, Binlie
    Ma, Zhiyan
    Zeng, Yongming
    Wang, Huaiming
    FRONTIERS IN GENETICS, 2021, 12
  • [5] Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma
    Shen, Bingbing
    Zhang, Guanqi
    Liu, Yunxun
    Wang, Jianguo
    Jiang, Jianxin
    GENES, 2022, 13 (10)
  • [6] Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
    Xia, Xinxin
    Tang, Ping
    Liu, Hui
    Li, Yuejun
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 798 - 808
  • [7] Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
    Kong, Weihao
    Wang, Xingyu
    Zuo, Xiaomin
    Mao, Zhongxiang
    Cheng, Ya
    Chen, Wei
    FRONTIERS IN GENETICS, 2020, 11
  • [8] Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
    Rui Li
    Chen Jin
    Weiheng Zhao
    Rui Liang
    Huihua Xiong
    BMC Gastroenterology, 22
  • [9] Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
    Li, Rui
    Jin, Chen
    Zhao, Weiheng
    Liang, Rui
    Xiong, Huihua
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [10] Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma
    Chen, Dan
    Li, Xiaoting
    Li, Hui
    Wang, Kai
    Tian, Xianghua
    JOURNAL OF ONCOLOGY, 2022, 2022